The table below shows ATAI Life Sciences N.V.'s cash flow statement line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$82.44M
-$84.12M
-$104.47M
-$63.25M
-$20.77M
Capital expenditure
$6.00K
$259.00K
$773.00K
$173.00K
$59.00K
Investing cash flow
$59.17M
-$53.30M
-$86.85M
-$81.28M
-$28.27M
Dividends paid
-
-
-
-
-
Stock buybacks
-
-
ATAI operating cash flow (10-K history)
ATAI Life Sciences N.V. reported operating cash flow of -$82.44M for fiscal year 2024. That is up 2.0% from -$84.12M in fiscal 2023. Over the 5 fiscal years shown, operating cash flow declined from -$20.77M (FY 2020) to -$82.44M. Figures come from the company's audited annual reports as filed with the SEC.